Literature DB >> 15051926

Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma.

Yasuhiro Oshimo1, Naohide Oue, Yoshitsugu Mitani, Hirofumi Nakayama, Yasuhiko Kitadai, Kazuhiro Yoshida, Yoshiaki Ito, Kazuaki Chayama, Wataru Yasui.   

Abstract

The RUNX3 gene is a member of the Runt domain family of transcription factors that are master regulators of gene expression in major developmental pathways. Recently, lack of RUNX3 function was found to be associated with genesis and progression of gastric carcinoma. We studied methylation of CpG islands in the RUNX3 gene by methylation-specific PCR in 80 gastric carcinoma specimens, 45 corresponding non-neoplastic mucosae, and 7 gastric carcinoma cell lines. We also measured levels of RUNX3 mRNA in 50 of the gastric carcinoma cases by quantitative RT-PCR and in the gastric carcinoma cell lines by RT-PCR. Hypermethylation of the RUNX3 promoter was found in 57 (71%) of 80 gastric carcinomas, and promoter hypermethylation of RUNX3 occurred more frequently in intestinal and diffuse-adherent type tumors than in diffuse-scattered type tumors (p = 0.046). Reduced RUNX3 expression was associated with promoter hypermethylation (p = 0. 036), however, there was no correlation between RUNX3 mRNA expression levels and T grade, N grade, tumor stage, or histological type. In corresponding non-neoplastic mucosae, hypermethylation of the RUNX3 promoter was found in 38 (84%) of 45 specimens. Among seven gastric carcinoma cell lines, three cell lines (MKN-28, MKN-74, TMK-1) with diminished expression of RUNX3 had promoter methylation and three cell lines (MKN-1, MKN-7, MKN-45) with RUNX3 expression showed no promoter methylation. Our results overall suggest that transcriptional inactivation of RUNX3 by promoter hypermethylation may participate in the stomach carcinogenesis. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15051926     DOI: 10.1159/000076468

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  26 in total

1.  Opposing effects of Runx2 and estradiol on breast cancer cell proliferation: in vitro identification of reciprocally regulated gene signature related to clinical letrozole responsiveness.

Authors:  Nyam-Osor Chimge; Sanjeev K Baniwal; Jingqin Luo; Simon Coetzee; Omar Khalid; Benjamin P Berman; Debu Tripathy; Matthew J Ellis; Baruch Frenkel
Journal:  Clin Cancer Res       Date:  2011-12-06       Impact factor: 12.531

2.  Epigenetic changes induced by oxidative stress in colorectal cancer cells: methylation of tumor suppressor RUNX3.

Authors:  Kyoung Ah Kang; Rui Zhang; Gi Young Kim; Suk Chul Bae; Jin Won Hyun
Journal:  Tumour Biol       Date:  2012-01-25

3.  Inactivation of RUNX3 predicts poor prognosis in esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy.

Authors:  Mo Shi; Zhou Wang; Xiang-Yan Liu; Dong Chen
Journal:  Med Oncol       Date:  2014-11-13       Impact factor: 3.064

4.  Methylation of the Tumor Suppressor Gene RUNX3 in Human Gastric Carcinoma.

Authors:  Hyun Joo Song; Ki-Nam Shim; Yang-Hee Joo; Seong-Eun Kim; Sung-Ae Jung; Kwon Yoo
Journal:  Gut Liver       Date:  2008-09-30       Impact factor: 4.519

Review 5.  Helicobacter pylori eradication to prevent gastric cancer: underlying molecular and cellular mechanisms.

Authors:  Shingo Tsuji; Masahiko Tsujii; Hiroaki Murata; Tsutomu Nishida; Masato Komori; Masakazu Yasumaru; Shuji Ishii; Yoshiaki Sasayama; Sunao Kawano; Norio Hayashi
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

6.  H. pylori-Eradication Therapy Increases RUNX3 Expression in the Glandular Epithelial Cells in Enlarged-Fold Gastritis.

Authors:  Masayuki Suzuki; Hidekazu Suzuki; Yuriko Minegishi; Kosei Ito; Toshihiro Nishizawa; Toshifumi Hibi
Journal:  J Clin Biochem Nutr       Date:  2010-04-10       Impact factor: 3.114

7.  Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis.

Authors:  Sanjeev K Baniwal; Omar Khalid; Yankel Gabet; Ruchir R Shah; Daniel J Purcell; Deepak Mav; Alice E Kohn-Gabet; Yunfan Shi; Gerhard A Coetzee; Baruch Frenkel
Journal:  Mol Cancer       Date:  2010-09-23       Impact factor: 27.401

8.  Identification and validation that up-expression of HOXA13 is a novel independent prognostic marker of a worse outcome in gastric cancer based on immunohistochemistry.

Authors:  Yang Han; Wei-Wei Tu; Yu-Gang Wen; Da-Peng Li; Guo-Qiang Qiu; Hua-Mei Tang; Zhi-Hai Peng; Chong-Zhi Zhou
Journal:  Med Oncol       Date:  2013-04-17       Impact factor: 3.064

Review 9.  The RUNX family in breast cancer: relationships with estrogen signaling.

Authors:  N-O Chimge; B Frenkel
Journal:  Oncogene       Date:  2012-10-08       Impact factor: 9.867

10.  Src kinase phosphorylates RUNX3 at tyrosine residues and localizes the protein in the cytoplasm.

Authors:  Yun-Mi Goh; Senthilkumar Cinghu; Eileen Tan Hwee Hong; You-Soub Lee; Jang-Hyun Kim; Ju-Won Jang; Ying-Hui Li; Xin-Zi Chi; Kyeong-Sook Lee; Heejun Wee; Yoshiaki Ito; Byung-Chul Oh; Suk-Chul Bae
Journal:  J Biol Chem       Date:  2010-01-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.